Sardomozide dihydrochloride
Based on 10 publication(s) in Google Scholar
Sardomozide dihydrochloride is an S-adenosylmethionine decarboxylase (SAMDC) inhibitor with an IC50 of 5 nM.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 99.73%
- CAS No.: 138794-73-7
- Formule: C11H16Cl2N6
- Masse moléculaire:303.19
-
Stockage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-13610A
N1,N11-Diethylnorspermine tetrahydrochlorideAnticancer Agent -
HY-B0744
EflornithineOrnithine Decarboxylase Inhibitor -
HY-B0744B
Eflornithine hydrochloride hydrateOrnithine Decarboxylase Inhibitor -
HY-106634
MitoguazoneS-adenosyl-methionine Decarboxylase Inhibitor -
HY-10219
RapamycinmTOR Inhibitor -
HY-124617A
AMXT-1501 tetrahydrochlorideBacterial Agent And Polyamine Transport System Inhibitor -
HY-12305
Q-VD-OPhPan-caspase Inhibitor -
HY-100579
Ferrostatin-1Ferroptosis Inhibitor -
HY-100558
Bafilomycin A1V-ATPase Inhibitor -
HY-B1777
SpermineEndogenous Metabolite -
HY-10162
OlaparibPARP Inhibitor -
HY-108314A
GC7 SulfateDHPS Inhibitor
Publications Citing Use of MedChemExpress (MCE) Sardomozide dihydrochloride
More- Nature. 2026 Jul;655(8121):240-250. [Abstract]
- Cell. 2020 Jun 11;181(6):1329-1345.e24. [Abstract]
- Sci Adv. 2023 May 19;9(20):eade0718. [Abstract]
- Cell Rep. 2025 Jan 28;44(1):115123. [Abstract]
- mSystems. 2024 May 16;9(5):e0024624. [Abstract]
- iScience. 2026 Aug 6;29(8):117000.
- Metabolomics. 2025 Jun 14;21(4):82. [Abstract]
- Preprints. 2025 May 22.
- bioRxiv. 2024 Nov 17:2024.08.24.609500. [Abstract]
- SSRN. 2024 Mar 14.
Customer Validation & Images
-
Others
-
Bio/Physico-chemical Assay
-
RT-PCR
-
Bio/Physico-chemical Assay
-
Cell Proliferation/Viability Assay
Activité biologique
Description
IC50 & Target
IC50: 5 nM (SAMDC)[1]
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| T-24 | IC50 |
0.71 μM
Compound: 17
|
Inhibition Human T24 bladder carcinoma cells
Inhibition Human T24 bladder carcinoma cells
|
[PMID: 8340919] |
In Vitro
Sardomozide is a S-adenosylmethionine decarboxylase (SAMDC) inhibitor with an IC50 of 5 nM in cell assay. Following treatment for 48 h with 3 μM Sardomozide, intracellular SAMDC activity is reduced to 10% of control[1]. When the CHO/664 cells are grown in the presence of Sardomozide and during treatment with DENSPM, vacuole formation is not observed, and these cells are growth-inhibited and contain levels of DENSPM similar to the parental CHO cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 138794-73-7
-
Appearance Solid
-
Masse moléculaire 303.19
-
Formule C11H16Cl2N6
-
Color White to off-white
-
SMILES
N=C(C1=CC=CC2=C1CC/C2=N\NC(N)=N)N.[H]Cl.[H]Cl
-
Synonyms
CGP 48664A
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (10)
-
Journal Impact Factor
-
Most Recent
-
Nature
2026 Jul;655(8121):240-250. PMID: 42236947 -
Cell
2020 Jun 11;181(6):1329-1345.e24. PMID: 32445698
Sardomozide dihydrochloride purchased from MedChemExpress. Usage Cited in: Cell. 2020 Jun 11;181(6):1329-1345.e24. [Abstract]
Dose dependent Sardomozide dihydrochloride inhibition (7 days) of SAM decarboxylation (polyamine metabolism) diminishes PFA cell survival in 1% O2.
-
Sci Adv
Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation. [Abstract]2023 May 19;9(20):eade0718. PMID: 37205755
Sardomozide dihydrochloride purchased from MedChemExpress. Usage Cited in: Sci Adv. 2023 May 19;9(20):eade0718. [Abstract]
Percentage of IFN-γ+ and mean fluorescence intensity (MFI) of Ki-67 in CD8+ T cells after anti-CD3 antibody stimulation versus anti-CD3 antibody plus rSema4A stimulation with or without sardomozide dihydrochloride (10 μM) and eflornithine hydrochloride hydrate (500 μM).
-
Cell Rep
2025 Jan 28;44(1):115123. PMID: 39932195
Sardomozide dihydrochloride purchased from MedChemExpress. Usage Cited in: Cell Rep. 2025 Jan 28;44(1):115123. [Abstract]
Diagram of the experimental plan for Sardomozide dihydrochloride (Sardo) treatment on C2C12 myotubes.
-
mSystems
Mucin alleviates colonic barrier dysfunction by promoting spermine accumulation through enhanced arginine metabolism in Limosilactobacillus mucosae. [Abstract]2024 May 16;9(5):e0024624. PMID: 38564708
Sardomozide dihydrochloride purchased from MedChemExpress. Usage Cited in: mSystems. 2024 May 16;9(5):e0024624. [Abstract]
The concentration of putrescine, spermidine, and spermine concentrations of L. mucosae culture in the MRS broth with or without mucin and sardomozide dihydrochloride.
Sardomozide dihydrochloride purchased from MedChemExpress. Usage Cited in: mSystems. 2024 May 16;9(5):e0024624. [Abstract]
qPCR analysis of tight-junction protein expression in LS174T cells. The letters at the top of the bar plot indicate statistically significant differences between the groups (P < 0.05). LM, normal culture supernatant; LMM, co-cultured supernatant with mucin; LMS, co-cultured supernatant with 8 µM spermine; LMMS, co-cultured supernatant with mucin and sardomozide dihydrochloride; Sper, 8 µM spermine.
-
-
Metabolomics
SAM486A-induced inhibition of AMD1: metabolic and epigenetic implications in non-small cell lung cancer cells. [Abstract]2025 Jun 14;21(4):82. PMID: 40515967 -
-
bioRxiv
2024 Nov 17:2024.08.24.609500. PMID: 39253442 -
Solvant et solubilité
In Vitro:
DMSO : 10 mg/mL (32.98 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : 3.85 mg/mL (12.70 mM; ultrasonic and warming and heat to 60°C)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 1 mg/mL (3.30 mM); Clear solution
This protocol yields a clear solution of ≥ 1 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (10.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 1 mg/mL (3.30 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 1 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (10.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureté et documentation
-
Fiche technique (279 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Regenass U, et al. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity. Cancer Res. 1994 Jun 15;54(12):3210-7. [Content Brief]
[2]. Kramer DL, et al. Lysosomal sequestration of polyamine analogues in Chinese hamster ovary cells resistant to the S-adenosylmethionine decarboxylase inhibitor, CGP-48664. Cancer Res. 1998 Sep 1;58(17):3883-90. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O / DMSO | 1 mM | 3.2983 mL | 16.4913 mL | 32.9826 mL | 82.4565 mL |
| 5 mM | 0.6597 mL | 3.2983 mL | 6.5965 mL | 16.4913 mL | |
| 10 mM | 0.3298 mL | 1.6491 mL | 3.2983 mL | 8.2457 mL | |
| DMSO | 15 mM | 0.2199 mL | 1.0994 mL | 2.1988 mL | 5.4971 mL |
| 20 mM | 0.1649 mL | 0.8246 mL | 1.6491 mL | 4.1228 mL | |
| 25 mM | 0.1319 mL | 0.6597 mL | 1.3193 mL | 3.2983 mL | |
| 30 mM | 0.1099 mL | 0.5497 mL | 1.0994 mL | 2.7486 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Sardomozide dihydrochloride Related Classifications
HY-13746B Related Classifications
Powered by Bioz